To evaluate NRF2-dependent regulation of these genes, we generated two KEAP1-mutant NSCLC cell lines (A549 and NCI-H460) stably integrated with a doxycycline (dox)-inducible shRNA targeting NRF2. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.